Trial Profile
Effect of BMS-663068 on the Pharmacokinetics of Rosuvastatin
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs Fostemsavir (Primary) ; Rosuvastatin
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 25 Feb 2016 Results presented at the 23rd Conference on Retroviruses and Opportunistic Infections
- 09 Feb 2015 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
- 12 Sep 2014 New trial record